The report will be delivered in 2-3 business days.

Metabolic Disorders Drugs Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 300 | Published : January 2019 | SKU CODE : 5283 | Format :


Metabolic Disorders Drugs Market Characteristics

The metabolic disorders drugs market consists of sales of metabolic disorders drugs and related services by entities (organizations, sole traders and partnerships) that produce metabolic disorders drugs to treat metabolic diseases. This industry includes establishments that produce drugs such as insulin, pramlintide and other drugs to treat diabetes, anti-thyroid drugs to treat hyperthyroidism, and other drugs to treat pituitary gland, adrenal gland and parathyroid gland disorders.

Competitive Landscape of the Metabolic Disorders Drugs Market

Major players in the global metabolic disorders drugs market include Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co.

Metabolic Disorders Drugs Market Size

The metabolic disorders drugs market expected to reach a value of nearly $74.57 billion by 2022, significantly growing at a CAGR of 10.2% during the forecast period. The growth in the metabolic disorders drugs market is due rapid growth in diabetic patients which, according to the World Health Organization, is expected to be the world’s seventh leading cause of death in 2030.

However, the market for metabolic disorders drugs is expected to face certain restraints from several factors such as increasing government regulation and changing trends to ayurvedic treatments.

Metabolic Disorders Drugs Market Segmentation

The global metabolic disorders drugs market is further segmented based on type and geography.
By Type - The metabolic disorders drugs market is segmented into anti diabetics drugs, anti-thyroid drugs, others (hyperparathyroidism, hypopituitarism, hypoadrenalism) among these segments, the anti-diabetics drugs market accounts for the largest share in the global metabolic disorders drugs market.
By Geography - The global metabolic disorders drugs is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global metabolic disorders drugs market.
Trends in the Metabolic Disorders Drugs Market
Administration (FDA) has approved various enzyme replacement therapies for the treatment of metabolic disorders. Enzyme replacement therapy is used for treatment of rare genetic disorders through purified human, animal or recombinant enzymes. In December 2015, the FDA approved an enzyme replacement therapy Kanuma that can be used to treat adult and pediatric patients suffering from lysosomal acid lipase deficiency, a metabolic disorder that causes problems with the breakdown and use of fats and cholesterol in the body. Similarly, in October 2015, FDA had announced the approval of Strensiq, a drug that can be used for the treatment of perinatal, infantile and juvenile-onset hypophosphatasia, which is a metabolic disorder affecting multiple body systems. Potential Opportunities in the Metabolic Disorders Drugs Market With rapid growth due to growing diabetic population worldwide, and increasing academia-industry collaborations to develop new drugs for treatment of metabolic disorders the scope and potential for the global metabolic disorders drugs market is expected to significantly rise in the forecast period.

    1. Executive Summary

    2. Report Structure

    3. Metabolic Disorders Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Metabolic Disorders Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Metabolic Disorders Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Metabolic Disorders Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Metabolic Disorders Drugs Market Trends And Strategies

    8. Metabolic Disorders Drugs Market Size And Growth

    8.1. Market Size

    8.2. Historic Market Growth, Value ($ Billion)

    8.2.1. Drivers Of The Market

    8.2.2. Restraints On The Market

    8.3. Forecast Market Growth, Value ($ Billion)

    8.3.1. Drivers Of The Market

    8.3.2. Restraints On The Market

    9. Metabolic Disorders Drugs Market Regional Analysis

    9.1. Global Metabolic Disorders Drugs Market, 2018, By Region, Value ($ Billion)

    9.2. Global Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Region

    9.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

    10. Metabolic Disorders Drugs Market Segmentation

    10.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)

    10.1.1. Anti Diabetics drugs

    10.1.2. Anti-Thyroid drugs

    10.1.3. Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

    11. Metabolic Disorders Drugs Market Metrics

    11.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global

    11.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014 - 2022, Global

    12. Asia-Pacific Metabolic Disorders Drugs Market

    12.1. Asia-Pacific Metabolic Disorders Drugs Market Overview

    12.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)

    12.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country

    12.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country

    12.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics

    12.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries

    12.6. Asia-Pacific Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    12.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis

    12.7.1. China Metabolic Disorders Drugs Market

    12.7.1.1. China Metabolic Disorders Drugs Market Overview

    12.7.1.2. China Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.1.3. China Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    12.7.1.4. China Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    12.7.2. Australia Metabolic Disorders Drugs Market

    12.7.2.1. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.2.2. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    12.7.2.3. Australia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    12.7.3. Hong Kong Metabolic Disorders Drugs Market

    12.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.4. India Metabolic Disorders Drugs Market

    12.7.4.1. India Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.4.2. India Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    12.7.4.3. India Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    12.7.5. Indonesia Metabolic Disorders Drugs Market

    12.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.6. Japan Metabolic Disorders Drugs Market

    12.7.6.1. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.6.2. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    12.7.6.3. Japan Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    12.7.7. Malaysia Metabolic Disorders Drugs Market

    12.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.8. New Zealand Metabolic Disorders Drugs Market

    12.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.9. Philippines Metabolic Disorders Drugs Market

    12.7.9.1. Philippines Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.10. Singapore Metabolic Disorders Drugs Market

    12.7.10.1. Singapore Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.11. South Korea Metabolic Disorders Drugs Market

    12.7.11.1. South Korea Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.12. Thailand Metabolic Disorders Drugs Market

    12.7.12.1. Thailand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    12.7.13. Vietnam Metabolic Disorders Drugs Market

    12.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13. Western Europe Metabolic Disorders Drugs Market

    13.1. Western Europe Metabolic Disorders Drugs Market Overview

    13.2. Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)

    13.3. Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country

    13.4. Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country

    13.5. Western Europe, Metabolic Disorders Drugs Market Metrics

    13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Western Europe Countries

    13.6. Western Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    13.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis

    13.7.1. Austria Metabolic Disorders Drugs Market

    13.7.1.1. Austria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.2. Belgium Metabolic Disorders Drugs Market

    13.7.2.1. Belgium Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.3. Denmark Metabolic Disorders Drugs Market

    13.7.3.1. Denmark Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.4. Finland Metabolic Disorders Drugs Market

    13.7.4.1. Finland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.5. France Metabolic Disorders Drugs Market

    13.7.5.1. France Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.5.2. France Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    13.7.5.3. France Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    13.7.6. Germany Metabolic Disorders Drugs Market

    13.7.6.1. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.6.2. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    13.7.6.3. Germany Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    13.7.7. Ireland Metabolic Disorders Drugs Market

    13.7.7.1. Ireland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.8. Italy Metabolic Disorders Drugs Market

    13.7.8.1. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.8.2. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    13.7.8.3. Italy Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    13.7.9. Netherlands Metabolic Disorders Drugs Market

    13.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.10. Norway Metabolic Disorders Drugs Market

    13.7.10.1. Norway Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.11. Portugal Metabolic Disorders Drugs Market

    13.7.11.1. Portugal Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.12. Spain Metabolic Disorders Drugs Market

    13.7.12.1. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.12.2. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    13.7.12.3. Spain Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    13.7.13. Sweden Metabolic Disorders Drugs Market

    13.7.13.1. Sweden Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.14. Switzerland Metabolic Disorders Drugs Market

    13.7.14.1. Switzerland Metabolic Disorders Drugs Market2013 - 2022, Value ($ Billion)

    13.7.15. UK Metabolic Disorders Drugs Market

    13.7.15.1. UK Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    13.7.15.2. UK Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    13.7.15.3. UK Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    14. Eastern Europe Metabolic Disorders Drugs Market

    14.1. Eastern Europe Metabolic Disorders Drugs Market Overview

    14.2. Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)

    14.3. Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country

    14.4. Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country

    14.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics

    14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Eastern Europe Countries

    14.6. Eastern Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    14.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis

    14.7.1. Czech Republic Metabolic Disorders Drugs Market,  

    14.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    14.7.2. Poland Metabolic Disorders Drugs Market

    14.7.2.1. Poland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    14.7.3. Romania Metabolic Disorders Drugs Market

    14.7.3.1. Romania Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    14.7.4. Russia Metabolic Disorders Drugs Market

    14.7.4.1. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    14.7.4.2. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    14.7.4.3. Russia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    15. North America Metabolic Disorders Drugs Market

    15.1. North America Metabolic Disorders Drugs Market Overview

    15.2. North America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)

    15.3. North America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country

    15.4. North America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country

    15.5. North America, Metabolic Disorders Drugs Market Metrics

    15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, North America Countries

    15.6. North America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    15.7. North America Metabolic Disorders Drugs Market: Country Analysis

    15.7.1. Canada Metabolic Disorders Drugs Market

    15.7.1.1. Canada Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    15.7.2. Mexico Metabolic Disorders Drugs Market

    15.7.2.1. Mexico Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    15.7.3. USA Metabolic Disorders Drugs Market

    15.7.3.1. USA Metabolic Disorders Drugs Market Overview

    15.7.3.2. USA Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    15.7.3.3. USA Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    15.7.3.4. USA Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    16. South America Metabolic Disorders Drugs Market

    16.1. South America Metabolic Disorders Drugs Market Overview

    16.2. South America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)

    16.3. South America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country

    16.4. South America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country

    16.5. South America, Metabolic Disorders Drugs Market Metrics

    16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, South America Countries

    16.6. South America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    16.7. South America Metabolic Disorders Drugs Market: Country Analysis

    16.7.1. Argentina Metabolic Disorders Drugs Market

    16.7.1.1. Argentina Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    16.7.2. Brazil Metabolic Disorders Drugs Market

    16.7.2.1. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    16.7.2.2. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)

    16.7.2.3. Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    16.7.3. Chile Metabolic Disorders Drugs Market

    16.7.3.1. Chile Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    16.7.4. Colombia Metabolic Disorders Drugs Market

    16.7.4.1. Colombia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    16.7.5. Peru Metabolic Disorders Drugs Market

    16.7.5.1. Peru Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    16.7.6. Venezuela Metabolic Disorders Drugs Market

    16.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    17. Middle East Metabolic Disorders Drugs Market

    17.1. Middle East Metabolic Disorders Drugs Market Overview

    17.2. Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)

    17.3. Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country

    17.4. Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country

    17.5. Middle East, Metabolic Disorders Drugs Market Metrics

    17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Middle East Countries

    17.6. Middle East Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    17.7. Middle East Metabolic Disorders Drugs Market: Country Analysis

    17.7.1. Saudi Arabia Metabolic Disorders Drugs Market

    17.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    17.7.2. Israel Metabolic Disorders Drugs Market

    17.7.2.1. Israel Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    17.7.3. Turkey Metabolic Disorders Drugs Market

    17.7.3.1. Turkey Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    17.7.4. UAE Metabolic Disorders Drugs Market

    17.7.4.1. UAE Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    18. Africa Metabolic Disorders Drugs Market

    18.1. Africa Metabolic Disorders Drugs Market Overview

    18.2. Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)

    18.3. Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country

    18.4. Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country

    18.5. Africa, Metabolic Disorders Drugs Market Metrics

    18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Africa Countries

    18.6. Africa Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    18.7. Africa Metabolic Disorders Drugs Market: Country Analysis

    18.7.1. Egypt Metabolic Disorders Drugs Market

    18.7.1.1. Egypt Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    18.7.2. Nigeria Metabolic Disorders Drugs Market

    18.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    18.7.3. South Africa Metabolic Disorders Drugs Market

    18.7.3.1. South Africa Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)

    19. Metabolic Disorders Drugs Market Competitive Landscape

    19.1. Competitive Market Overview

    19.2. Market Shares

    19.3. Company Profiles

    19.3.1. Sanofi S.A

    19.3.1.1. Company Overview

    19.3.1.2. Company Metabolic Disorders Drugs Market Structure And Strategy

    19.3.1.3. Company Metabolic Disorders Drugs Market Products And Services

    19.3.1.4. Financial Performance

    19.3.2. Novo Nordisk A/S

    19.3.2.1. Company Overview

    19.3.2.2. Company Metabolic Disorders Drugs Market Structure And Strategy

    19.3.2.3. Company Metabolic Disorders Drugs Market Products And Services

    19.3.2.4. Financial Performance

    19.3.3. AstraZeneca Plc

    19.3.3.1. Company Overview

    19.3.3.2. Company Metabolic Disorders Drugs Market Structure And Strategy

    19.3.3.3. Company Metabolic Disorders Drugs Market Products And Services

    19.3.3.4. Financial Performance

    19.3.4. Johnson & Johnson

    19.3.4.1. Company Overview

    19.3.4.2. Company Metabolic Disorders Drugs Market Structure And Strategy

    19.3.4.3. Company Metabolic Disorders Drugs Market Products And Services

    19.3.4.4. Financial Performance

    19.3.5. Merck & Co

    19.3.5.1. Company Overview

    19.3.5.2. Company Metabolic Disorders Drugs Market Structure And Strategy

    19.3.5.3. Company Metabolic Disorders Drugs Market Products And Services

    19.3.5.4. Financial Performance

    20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

    21. Market Background: Pharmaceutical Drugs Market

    21.1. Pharmaceutical Drugs Market Characteristics

    21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global

    21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)

    21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region

    21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

    22. Recommendations

    22.1. Global Metabolic Disorders Drugs Market In 2022- Growth Countries

    22.2. Global Metabolic Disorders Drugs Market In 2022- Growth Segments

    22.3. Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

    23. Appendix

    23.1. NAICS Definitions Of Industry Covered In This Report

    23.2. Abbreviations

    23.3. Currencies

    23.4. Research Inquiries

    23.5. The Business Research Company

    24. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Metabolic Disorders Drugs Market, 2018, By Region, Value ($ Billion)
  • Table 4: Global Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Table 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 7: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • Table 8: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014 - 2022, Global
  • Table 9: Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 10: Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 11: Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 12: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • Table 13: Asia-Pacific Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 14: China Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 15: China Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 16: China Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 17: Australia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 18: Australia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 19: Australia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 20: Hong Kong Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 21: India Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 22: India Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 23: India Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 24: Indonesia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 25: Japan Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 26: Japan Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 27: Japan Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 28: Malaysia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 29: New Zealand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 30: Philippines Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 31: Singapore Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 32: South Korea Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 33: Thailand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 34: Vietnam Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 35: Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 36: Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 37: Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 38: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • Table 39: Western Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 40: Austria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 41: Belgium Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 42: Denmark Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 43: Finland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 44: France Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 45: France Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 46: France Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 47: Germany Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 48: Germany Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 49: Germany Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 50: Ireland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 51: Italy Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 52: Italy Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 53: Italy Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 54: Netherlands Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 55: Norway Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 56: Portugal Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 57: Spain Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 58: Spain Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 59: Spain Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 60: Sweden Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 61: Switzerland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 62: UK Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 63: UK Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 64: UK Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 65: Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 66: Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 67: Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 68: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • Table 69: Eastern Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 70: Czech Republic Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 71: Poland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 72: Romania Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 73: Russia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 74: Russia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 75: Russia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 76: North America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 77: North America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 78: North America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 79: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, North America Countries
  • Table 80: North America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 81: Canada Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 82: Mexico Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 83: USA Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 84: USA Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 85: USA Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 86: South America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 87: South America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 88: South America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 89: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, South America Countries
  • Table 90: South America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 91: South America Anti Diabetics drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 92: South America Anti-Thyroid drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 93: South America Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism) Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Table 94: Argentina Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 95: Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 96: Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Table 97: Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 98: Chile Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 99: Colombia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 100: Peru Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 101: Venezuela Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 102: Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 103: Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 104: Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 105: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Middle East Countries
  • Table 106: Middle East Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 107: Saudi Arabia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 108: Israel Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 109: Turkey Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 110: UAE Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 111: Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Table 112: Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Table 113: Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Table 114: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Africa Countries
  • Table 115: Africa Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 116: Egypt Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 117: Nigeria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Table 118: South Africa Metabolic Disorders Drugs Market2014 - 2022, Value ($ Billion)
  • Table 119: Sanofi S.A Financial Performance
  • Table 120: Novo Nordisk A/S Financial Performance
  • Table 121: AstraZeneca Plc Financial Performance
  • Table 122: Johnson & Johnson Financial Performance
  • Table 123: Merck & Co Financial Performance
  • Table 124: Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022, Growth, By Segment, Value ($ Billion), Global
  • Table 125: Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • Table 126: Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Table 127: Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Table 128: Global Metabolic Disorders Drugs Market In 2022- Growth Countries
  • Table 129: Global Metabolic Disorders Drugs Market In 2022- Growth Segments
  • Table 130: Global Metabolic Disorders Drugs Market In 2022- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Metabolic Disorders Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 4: Global Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 5: Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Metabolic Disorders Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 7: Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • Figure 8: Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2014 - 2022, Global
  • Figure 9: Asia-Pacific, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 10: Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 11: Asia-Pacific, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 12: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • Figure 13: Asia-Pacific Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 14: China Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 15: China Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 16: China Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 17: Australia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 18: Australia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 19: Australia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 20: Hong Kong Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 21: India Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 22: India Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 23: India Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 24: Indonesia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 25: Japan Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 26: Japan Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 27: Japan Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 28: Malaysia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 29: New Zealand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 30: Philippines Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 31: Singapore Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 32: South Korea Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 33: Thailand Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 34: Vietnam Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 35: Western Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 36: Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 37: Western Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 38: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • Figure 39: Western Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 40: Austria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 41: Belgium Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 42: Denmark Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 43: Finland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 44: France Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 45: France Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 46: France Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 47: Germany Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 48: Germany Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 49: Germany Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 50: Ireland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 51: Italy Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 52: Italy Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 53: Italy Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 54: Netherlands Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 55: Norway Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 56: Portugal Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 57: Spain Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 58: Spain Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 59: Spain Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 60: Sweden Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 61: Switzerland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 62: UK Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 63: UK Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 64: UK Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 65: Eastern Europe, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 66: Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 67: Eastern Europe, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 68: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • Figure 69: Eastern Europe Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 70: Czech Republic Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 71: Poland Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 72: Romania Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 73: Russia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 74: Russia Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 75: Russia Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 76: North America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 77: North America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 78: North America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 79: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, North America Countries
  • Figure 80: North America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 81: Canada Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 82: Mexico Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 83: USA Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 84: USA Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 85: USA Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 86: South America, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 87: South America, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 88: South America, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 89: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, South America Countries
  • Figure 90: South America Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 91: South America Anti Diabetics drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 92: South America Anti-Thyroid drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 93: South America Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism) Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
  • Figure 94: Argentina Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 95: Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 96: Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Volume (Million Units)
  • Figure 97: Brazil Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 98: Chile Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 99: Colombia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 100: Peru Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 101: Venezuela Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 102: Middle East, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 103: Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 104: Middle East, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 105: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Middle East Countries
  • Figure 106: Middle East Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 107: Saudi Arabia Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 108: Israel Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 109: Turkey Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 110: UAE Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 111: Africa, Metabolic Disorders Drugs Market, 2018, By Country, Value ($ Billion)
  • Figure 112: Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • Figure 113: Africa, Metabolic Disorders Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • Figure 114: Per Capita Average Metabolic Disorders Drugs Expenditure, 2014 - 2022, Africa Countries
  • Figure 115: Africa Metabolic Disorders Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 116: Egypt Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 117: Nigeria Metabolic Disorders Drugs Market, 2014 - 2022, Value ($ Billion)
  • Figure 118: South Africa Metabolic Disorders Drugs Market2014 - 2022, Value ($ Billion)
  • Figure 119: Sanofi S.A Financial Performance
  • Figure 120: Novo Nordisk A/S Financial Performance
  • Figure 121: AstraZeneca Plc Financial Performance
  • Figure 122: Johnson & Johnson Financial Performance
  • Figure 123: Merck & Co Financial Performance
  • Figure 124: Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022, Growth, By Segment, Value ($ Billion), Global
  • Figure 125: Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • Figure 126: Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • Figure 127: Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • Figure 128: Global Metabolic Disorders Drugs Market In 2022- Growth Countries
  • Figure 129: Global Metabolic Disorders Drugs Market In 2022- Growth Segments
  • Figure 130: Global Metabolic Disorders Drugs Market In 2022- Growth Strategies
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)